A Long-Term Safety and Efficacy Study of Lorecivivint in Subjects With Osteoarthritis of the Knee
Clinical trial NCT04520607 · TERMINATED
Trial details
- NCT number
- NCT04520607
- Sponsor
- Biosplice Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-25
- Primary completion
- 2023-06-30
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.